Skip to main content

Table 2 Compliance to the salivary sampling protocol

From: Feasibility of home-based sampling of salivary cortisol and cortisone in healthy adults

  Total Baseline Follow-up
Number of samples, n(%)    
 1 day in B and FU 18 (94.74) 18 (94.74) 18 (94.74)
 2 days in B and FU* 18 (94.74) 18 (94.74) 18 (94.74)
 3 days in B and FU 15 (78.95) 15 (78.95) 17 (89.47)
Report sample time, n(%)    
 1 day in B and FU 16 (84.21) 16 (84.21) 17 (89.47)
 2 days in B and FU* 16 (84.21) 16 (84.21) 16 (84.21)
 3 days B and FU 10 (52.63) 13 (68.42) 12 (63.16)
Compliant to timing of S1, n(%)    
 1 day in B and FU 16 (84.21) 16 (84.21) 17 (89.47)
 2 days in B and FU* 16 (84.21) 16 (84.21) 16 (84.21)
 3 days in B and FU 10 (52.63) 12 (63.16) 12 (63.16)
Compliant to timing of the second and third sample, n(%)    
 1 day in B and FU 16 (84.21) 16 (84.21) 16 (84.21)
 2 days in B and FU* 16 (84.21) 16 (84.21) 16 (84.21)
 3 days in B and FU 11 (57.89) 14 (73.68) 12 (63.16)
  1. Total represents the number of participants that are compliant at both baseline and follow-up before exclusion
  2. Data are presented as numbers (percentage)
  3. B baseline, FU follow-up, S1 the salivary sample collected immediately upon awakening
  4. *: Corresponds to the definition of compliance (Table 1)